Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
319 hedge funds and large institutions have $7.96B invested in Syneos Health, Inc. Class A Common Stock in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 139 increasing their positions, 99 reducing their positions, and 39 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 99
27% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $8.51M
18% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 39
11% more capital invested
Capital invested by funds: $7.19B → $7.96B (+$766M)
2% more funds holding
Funds holding: 313 → 319 (+6)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$502M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$84.2M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$74.9M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$69.4M |
| 5 |
BlackRock
New York
|
+$63.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Advent International
Boston,
Massachusetts
|
-$351M |
| 2 |
THLTP
Thomas H. Lee (THL) Partners
Boston,
Massachusetts
|
-$311M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$97.7M |
| 4 |
HM
HealthCor Management
New York
|
-$54M |
| 5 |
Millennium Management
New York
|
-$37.5M |
SYNH Hedge Fund Activity: Q1 2021 in Review
319 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q1 2021, worth a combined $7.96B — up 11% from $7.19B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new SYNH positions and 39 closed out — a net gain of 7 holders — while 139 added to existing stakes and 99 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $502M. The largest seller was Advent International, cutting an estimated $351M.
- 319 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q1 2021, up from 313 in Q4 2020.
- Funds reported $7.96B of Syneos Health, Inc. Class A Common Stock stock for Q1 2021, up 11% quarter-over-quarter.
- 46 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q1 2021 and 39 closed out, a net change of +7 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q1 2021 was Wellington Management Group, an estimated $502M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q1 2021 was Advent International, an estimated $351M sold.
Based on aggregated 13F filings for Q1 2021.